Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 81 ~ 100 of 25905, Page 5 of 1296
81. Statement on actions to advance our comprehensive plan to reduce tobacco-related disease and death, through new efforts to improve the tobacco product application review process, including a newly proposed rule
03/28/2019 U.S. FOOD & DRUG ADMINISTRATION
82. Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before a U.S. Senate Subcommittee on Appropriations on FDA’s Fiscal Year 2020 budget
03/28/2019 U.S. FOOD & DRUG ADMINISTRATION
83. FDA approves new oral testosterone capsule for treatment of men with certain forms of hypogonadism
03/27/2019 U.S. FOOD & DRUG ADMINISTRATION
84. Statement on new steps to strengthen agency’s safety requirements aimed at mitigating risks associated with transmucosal immediate-release fentanyl products
03/27/2019 U.S. FOOD & DRUG ADMINISTRATION
85. Grow Your Own Garden
Enjoy the outdoors, get some exercise, create beauty, and grow your own food all at the same time! Learn more about the benefits of working in your own garden.
03/27/2019 American Cancer Society
86. FDA approves new oral drug to treat multiple sclerosis
03/26/2019 U.S. FOOD & DRUG ADMINISTRATION
87. Statement from FDA Commissioner Scott Gottlieb, M.D., on steps the Agency is taking to prevent potential medical device shortages and ensure safe and effective sterilization amid shutdown of a large contract sterilization facility
03/26/2019 U.S. FOOD & DRUG ADMINISTRATION
88. PubMed Approves Ophthalmology Retina for Indexing
New journal of the American Academy of Ophthalmology earns scientific quality distinction in just two years.
03/26/2019 American Academy of Ophthalmology
89. Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., on efforts to promote and foster blood pathogen reduction technologies
03/26/2019 U.S. FOOD & DRUG ADMINISTRATION
90. Statement from FDA Commissioner Scott Gottlieb, M.D., on continued efforts to advance safe biotechnology innovations, and the deactivation of an import alert on genetically engineered salmon
03/08/2019 U.S. FOOD & DRUG ADMINISTRATION
91. FDA takes steps to help reduce risks associated with surgical staplers and implantable staples
03/08/2019 U.S. FOOD & DRUG ADMINISTRATION
92. Cancer Survivor Blueprint Aims to Improve Lives of Both Survivors and Caregivers
This fourth chapter in the American Cancer Society (ACS) Cancer Control Blueprint describes what we know about the needs of survivors and their caregivers. It''s co-authored by ACS Vice President of Survivorship Catherine M. Alfano, PhD.
03/08/2019 American Cancer Society
93. AAOS Orthopaedic PAC Wins National Award Following Record-Breaking Year
03/08/2019 American Academy of Orthopaedic Surgeons
94. Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2019
Board Authorizes $6 Billion for Share Repurchases
03/08/2019 Medtronic
95. USDA and FDA Announce a Formal Agreement to Regulate Cell-Cultured Food Products from Cell Lines of Livestock and Poultry
03/07/2019 U.S. FOOD & DRUG ADMINISTRATION
96. Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s steps on naming of biological medicines to balance competition and safety for patients receiving these products
03/07/2019 U.S. FOOD & DRUG ADMINISTRATION
97. Medtronic Announces Closing of Public Offering of Senior Notes; Acceptance of Tendered Notes; and Redemption of Certain Senior Notes
03/07/2019 Medtronic
98. WHO unveils sweeping reforms in drive towards “triple billion” targets
03/06/2019 WHO
99. RSNA Offers Artificial Intelligence Course in Paris
OAK BROOK, Ill. (March 6, 2019)?The Radiological Society of North America (RSNA) continues its commitment to artificial intelligence (AI) education with two new regional courses this spring, the first of which will be held in Paris, France.
03/06/2019 Radiological Society of North America
100. Late-Breaking Data Presentations at ACC 2019 Highlight Abbott''s Leading Cardiovascular Portfolio
Five late-breaking data presentations at ACC 2019 showcase the breadth and depth of Abbott's cardiovascular portfolio / New late-breaking data highlight outcomes for key Abbott cardiovascular technologies: MitraClip, HeartMate 3, CardioMEMS and XIENCE
03/06/2019 Abbott
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱